What Kardigan Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 3 |
| Sells | 0 | 0 |
| Total trades | 23 | 23 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 73,193,440 | 73,193,440 |
| Disposed | 0 | 0 |
| Net activity | +73,193,440 | +73,193,440 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Arch Venture Partners XIII, Llc | Director | Jun 22 | Open-market buy · P | +1,250,000 | $16.00 | +$20M | 15,042,035 |
| Berns Paul L | Director | Jun 22 | Open-market buy · P | +1,250,000 | $16.00 | +$20M | 15,042,035 |
| Hrtg GPE, Llc | 10% owner | Jun 22 | Open-market buy · P | +3,125,000 | $16.00 | +$50M | 14,866,868 |
| Perceptive Advisors Llc | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Edelberg Jay | Chief Medical Officer | Jun 17 | Grant / award · A | +47,784 | — | — | 183,327 |
| Edelberg Jay | Chief Medical Officer | Jun 17 | Derivative Conversion · C | +97,587 | — | — | 135,543 |
| Giordano Douglas E. | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Gianakakos Anastasios | President & CEO | Jun 17 | Derivative Conversion · C | +498,692 | — | — | 498,692 |
| Gianakakos Anastasios | President & CEO | Jun 17 | Derivative Conversion · C | +41,001 | — | — | 2,422,520 |
| Gianakakos Anastasios | President & CEO | Jun 17 | Derivative Conversion · C | +28,702 | — | — | 5,665,090 |
| Walbert Timothy P | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Popovits Kimberly J | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Jahn Brianne | Chief Financial Officer | Jun 17 | Grant / award · A | +79,640 | — | — | 79,640 |
| Moriarty John B | Chief Legal Officer | Jun 17 | Grant / award · A | +47,784 | — | — | 47,784 |
| Berns Paul L | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Berns Paul L | Director | Jun 17 | Derivative Conversion · C | +13,792,035 | — | — | 13,792,035 |
| Meeker David P | Director | Jun 17 | Grant / award · A | +20,706 | — | — | 20,706 |
| Pasternak Andy | Chief Strategy Officer | Jun 17 | Grant / award · A | +79,640 | — | — | 79,640 |
| Arch Venture Partners XIII, Llc | Director | Jun 17 | Derivative Conversion · C | +13,792,035 | — | — | 13,792,035 |
| Hrtg GPE, Llc | 10% owner | Jun 17 | Derivative Conversion · C | +2,348,373 | — | — | 11,741,868 |
Loading...